freenome
Senior Computational Biologist I
At a Glance
- Location
- Brisbane, California, United States
- Work Regime
- hybrid
- Compensation
- base salary for new hires is $161,925 - $227,325 . You will also be eligible t
- Posted
- 2026-03-24T14:23:32-04:00
Requirements
Experience in the development of diagnostic devices in a regulated environment (PMA, 510(k), CE-IVD) preferred.
Experience with a variety of NGS methods (e.g., WGS, target capture with UMI, bisulfite sequencing, RNA-seq).
Compensation & Benefits
The US target range of our
base salary
for new hires is $161,925 - $227,325
. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @
freenome.com/job-openings/
for additional company information.
Responsibilities
As part of our team, you will apply your scientific expertise to the development of early, noninvasive tests for cancer detection.
With a strong background in bioinformatics, statistics, and molecular biology, you will develop, write, and execute analysis plans and reports for the development and characterization of Freenome’s in vitro diagnostic devices and regulatory filings.
You will work closely and cross-functionally with many teams, including Regulatory and Quality, Molecular Research and Development, Laboratory Operations, Biostatistics, Computational Science, and Engineering to enable the successful development of multiple molecular assays as part of Freenome’s diagnostic products.
The role reports to the Director of Computational Biology.
Plan and execute development experiments for Freenome’s multiomics cancer screening tests.
Partner cross-functionally with computational, development, regulatory, and quality leaders to develop and execute a regulated development strategy working toward FDA approval.